Conductive hydrogels based on agarose/alginate/chitosan for neural disorder therapy

Area of Science:

• Biomaterials Science
• Neuroscience
• Regenerative Medicine

Background:

• Loss of dopaminergic neurons causes central nervous system dysfunction, impacting motor control and behavior.
• Chitosan (CS) hydrogels exhibit poor conductivity, limiting their neural tissue applications.
• Developing conductive biomaterials is crucial for neural tissue engineering and treating neurodegenerative diseases.

Purpose of the Study:

• To synthesize electroactive carbohydrate-based hydrogels with enhanced conductivity.
• To evaluate the hydrogels' potential to mimic the neural tissue microenvironment for cell culture.
• To investigate the differentiation of olfactory ecto-mesenchymal stem cells (OE-MSCs) into dopaminergic neuron-like cells on these conductive scaffolds for potential Parkinson's disease therapy.

Main Methods:

• Synthesis of chitosan-oligoaniline (CS-oligoaniline) hydrogels.
• Characterization of hydrogel conductivity using UV-vis spectroscopy and cyclic voltammetry.
• Assessment of hydrogel mechanical properties and cellular activity.
• Induction of OE-MSC differentiation using a cocktail of neurotrophic factors (SHH, FGF8, bFGF, GDNF, BDNF).
• Evaluation of dopaminergic differentiation via real-time PCR, immunocytochemistry, and flow cytometry for markers like tyrosine hydroxylase (TH) and dopamine transporter (DAT).

Main Results:

• Chitosan hydrogel conductivity increased significantly from 10^-6 S/cm to approximately 10^-3 S/cm with CS-oligoaniline modification.
• Optimized hydrogels exhibited suitable conductivity and soft tissue-like modulus, supporting cellular activity and neural regeneration.
• OE-MSCs successfully differentiated into dopaminergic neuron-like cells on the conductive hydrogels, confirmed by the expression of TH and DAT markers.

Conclusions:

• CS-oligoaniline hydrogels represent a promising conductive biomaterial for neural tissue engineering.
• These scaffolds effectively support OE-MSC differentiation into dopaminergic neuron-like cells.
• This study provides a foundation for developing advanced platforms for neural disorder therapies, including Parkinson's disease.